Department of Gastrointestinal Surgery, Tokyo Medical and Dental University, Japan.
Department of Tokyo Metropolitan Health Policy Advisement, Tokyo Medical and Dental University, Japan.
Surgery. 2023 May;173(5):1169-1175. doi: 10.1016/j.surg.2022.12.022. Epub 2023 Feb 6.
Although the safety of robotic distal gastrectomy has been studied in several single-center trials, the nationwide outcomes of robotic distal gastrectomy that meet the requirements of Japanese national health insurance, such as facility case volume and skill level of the surgeon, are still not clear. The objective of this study was to evaluate the short-term outcomes of robotic distal gastrectomy, which was covered by national health insurance, compared to laparoscopic distal gastrectomy.
We retrieved gastric cancer cases with cStage I to III who underwent laparoscopic distal gastrectomy (15,539 patients) and robotic distal gastrectomy (1,312 patients) between April 2018 and March 2020 from the Diagnosis Procedure Combination database. We compared the frequency of postoperative complications, anesthesia time, and postoperative hospitalization days between laparoscopic distal gastrectomy and robotic distal gastrectomy using propensity score matching analysis.
The postoperative complication rate were not different between laparoscopic distal gastrectomy and robotic distal gastrectomy (odds ratio = 0.90, 95% confidence interval: 0.66 to 1.23, P = .52). The anesthesia time (minutes) was significantly longer (coefficient = 70.2, 95% confidence interval: 63.8 to 76.7, P < .001) and postoperative hospitalization (days) was significantly shorter (coefficient = -0.89, 95% confidence interval: -1.48 to -0.31, P = .003) in robotic distal gastrectomy than laparoscopic distal gastrectomy.
Robotic distal gastrectomy that met strict national health insurance coverage requirements in Japan was performed as safely as laparoscopic distal gastrectomy with reduced hospitalization days.
虽然机器人辅助远端胃切除术的安全性已在几项单中心试验中得到研究,但符合日本国家医疗保险要求的机器人辅助远端胃切除术(如手术设施例数和外科医生的技能水平)的全国性结果仍不清楚。本研究的目的是评估符合国家健康保险要求的机器人辅助远端胃切除术的短期结果,并将其与腹腔镜辅助远端胃切除术进行比较。
我们从诊断程序组合数据库中检索了 2018 年 4 月至 2020 年 3 月期间接受腹腔镜辅助远端胃切除术(15539 例)和机器人辅助远端胃切除术(1312 例)的 cStage I 至 III 期胃癌病例。我们使用倾向评分匹配分析比较了腹腔镜辅助远端胃切除术和机器人辅助远端胃切除术的术后并发症频率、麻醉时间和术后住院天数。
腹腔镜辅助远端胃切除术和机器人辅助远端胃切除术的术后并发症发生率无差异(优势比=0.90,95%置信区间:0.66 至 1.23,P=0.52)。机器人辅助远端胃切除术的麻醉时间(分钟)明显延长(系数=70.2,95%置信区间:63.8 至 76.7,P<0.001),术后住院时间(天)明显缩短(系数=-0.89,95%置信区间:-1.48 至-0.31,P=0.003)。
在日本,符合严格国家健康保险覆盖要求的机器人辅助远端胃切除术与腹腔镜辅助远端胃切除术一样安全,并且术后住院时间更短。